Erik J. Søderlund
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Erik J. Søderlund has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Gunnar Brunborg
Department of Chemical Toxicology, Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway
3 shared publications - Birgitte Lindeman
Department of Chemical Toxicology, Norwegian Institute of Public Health
2 shared publications - Jørn Andreas Holme
Department of Air and Noise, Norwegian Institute of Public Health, Oslo, Norway
2 shared publications - Ann-Karin Olsen
Department for Environment and Health, Section for Health Effects, The Climate and Environmental Research Institute NILU, Kjeller, Norway
1 shared publication Christine Bjørge
1 shared publicationErik Dybing
1 shared publication
Latest Publications
- Open Access
- 21 August 2007
- Published by Springer Nature in Molecular Cancer
- Vol. 6 (1) , 53
Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles
Background: Testicular germ cell tumors (TGCTs) respond well to cisplatin-based chemotherapy and show a low incidence of acquired resistance compared to most somatic tumors. The reasons for these specific characteristics are not known in detail but seem to be multifactorial. We have studied gene expression profiles of testicular and colon cancer derived cell lines treated with cisplatin. The main goal of this study was to identify novel gene expression profiles with their functional categories and the biochemical pathways that are associated with TGCT cells' response to cisplatin. Results: Genes that were differentially expressed between the TGCT cell lines vs the (somatic) HCT116 cell line, after cisplatin treatment, were identified using the significance analysis of microarrays (SAM) method. The response of TGCT cells was strikingly different from that of HCT116, and we identified 1794 genes that were differentially expressed. Functional classification of these genes showed that they participate in a variety of different and widely distributed functional categories and biochemical pathways. Database mining showed significant association of genes (n = 41) induced by cisplatin in our study, and genes previously reported to by expressed in differentiated TGCT cells. We identified 37 p53-responsive genes that were altered after cisplatin exposure. We also identified 40 target genes for two microRNAs, hsa-mir-372 and 373 that may interfere with p53 signaling in TGCTs. The tumor suppressor genes NEO1 and LATS2, and the estrogen receptor gene ESR1, all have binding sites for p53 and hsa-mir-372/373. NEO1 and LATS2 were down-regulated in TGCT cells following cisplatin exposure, while ESR1 was up-regulated in TGCT cells. Cisplatin-induced genes associated with terminal growth arrest through senescence were identified, indicating associations which were not previously described for TGCT cells. Conclusion: By linking our gene expression data to publicly available databases and literature, we provide a global pattern of cisplatin induced cellular response that is specific for testicular cancer cell lines. We have identified cisplatin-responsive functional classes and pathways, such as the angiogenesis, Wnt, integrin, and cadherin signaling pathways. The identification of differentially expressed genes in this study may contribute to a better understanding of the unusual sensitivity of TGCT to some DNA-damaging agents.
- 21 August 2007
- Published by Springer Nature in Molecular Cancer
- Vol. 6 (1) , 53
Open AccessMolecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles
Background: Testicular germ cell tumors (TGCTs) respond well to cisplatin-based chemotherapy and show a low incidence of acquired resistance compared to most somatic tumors. The reasons for these specific characteristics are not known in detail but seem to be multifactorial. We have studied gene expression profiles of testicular and colon cancer derived cell lines treated with cisplatin. The main goal of this study was to identify novel gene expression profiles with their functional categories and the biochemical pathways that are associated with TGCT cells' response to cisplatin. Results: Genes that were differentially expressed between the TGCT cell lines vs the (somatic) HCT116 cell line, after cisplatin treatment, were identified using the significance analysis of microarrays (SAM) method. The response of TGCT cells was strikingly different from that of HCT116, and we identified 1794 genes that were differentially expressed. Functional classification of these genes showed that they participate in a variety of different and widely distributed functional categories and biochemical pathways. Database mining showed significant association of genes (n = 41) induced by cisplatin in our study, and genes previously reported to by expressed in differentiated TGCT cells. We identified 37 p53-responsive genes that were altered after cisplatin exposure. We also identified 40 target genes for two microRNAs, hsa-mir-372 and 373 that may interfere with p53 signaling in TGCTs. The tumor suppressor genes NEO1 and LATS2, and the estrogen receptor gene ESR1, all have binding sites for p53 and hsa-mir-372/373. NEO1 and LATS2 were down-regulated in TGCT cells following cisplatin exposure, while ESR1 was up-regulated in TGCT cells. Cisplatin-induced genes associated with terminal growth arrest through senescence were identified, indicating associations which were not previously described for TGCT cells. Conclusion: By linking our gene expression data to publicly available databases and literature, we provide a global pattern of cisplatin induced cellular response that is specific for testicular cancer cell lines. We have identified cisplatin-responsive functional classes and pathways, such as the angiogenesis, Wnt, integrin, and cadherin signaling pathways. The identification of differentially expressed genes in this study may contribute to a better understanding of the unusual sensitivity of TGCT to some DNA-damaging agents.
- 28 February 2002
- Vol. 122 (6) , 615-8
[Factors contributing to interindividual variability to chemical toxicity].
Recognising toxicokinetic and toxicodynamic variability is important in the risk assessment of chemicals and may help to explain individual differences in susceptibility in exposed populations. This presentation discusses the influence of age, gender, disease and genetics on toxicokinetic and toxicodynamic processes. Neonates have a reduced capacity for metabolism and elimination of xenobiotics that may enhance chemical toxicity caused by a parent chemical. Furthermore, the brain, reproductive organs and immune system have critical postnatal periods of maturation where they appear highly sensitive to toxic effects that interfere with the maturation process and may lead to permanent structural or functional organ changes. In the elderly, a combination of reduced organ function, disease and use of pharmaceuticals contributes to enhanced chemical sensitivity reflected in an increased incidence of adverse drug reactions in this population. There is a high degree of functional polymorphism in biotransforming enzymes. Such polymorphisms have been shown to contribute to interindividual variability in chemical response. During the last few years, accounts have been given of several polymorphisms in genes with importance for toxicodynamic processes, such as DNA repair genes and receptor genes. However, further information is needed in order to evaluate the functional contribution of these polymorphisms to chemical sensitivity and health risk.
- 28 February 2002
- Vol. 122 (6) , 615-8
[Factors contributing to interindividual variability to chemical toxicity].
Recognising toxicokinetic and toxicodynamic variability is important in the risk assessment of chemicals and may help to explain individual differences in susceptibility in exposed populations. This presentation discusses the influence of age, gender, disease and genetics on toxicokinetic and toxicodynamic processes. Neonates have a reduced capacity for metabolism and elimination of xenobiotics that may enhance chemical toxicity caused by a parent chemical. Furthermore, the brain, reproductive organs and immune system have critical postnatal periods of maturation where they appear highly sensitive to toxic effects that interfere with the maturation process and may lead to permanent structural or functional organ changes. In the elderly, a combination of reduced organ function, disease and use of pharmaceuticals contributes to enhanced chemical sensitivity reflected in an increased incidence of adverse drug reactions in this population. There is a high degree of functional polymorphism in biotransforming enzymes. Such polymorphisms have been shown to contribute to interindividual variability in chemical response. During the last few years, accounts have been given of several polymorphisms in genes with importance for toxicodynamic processes, such as DNA repair genes and receptor genes. However, further information is needed in order to evaluate the functional contribution of these polymorphisms to chemical sensitivity and health risk.
- 1 June 1993
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 14 (6) , 1125-1131
Genotoxic effects of cyclopenta-fused polycyclic aromatic hydrocarbons in isolated rat hepatocytes and rabbit lung cells
Benz[j]aceanthrylene (B[j]A) and benz[l)aceanthrylene (B[l]A), two isomeric cyclopenta polycyclic aromatic hydrocarbons (CP-PAH) structurally related to 3-methylcholanthrene, were studied with respect to their genotoxic effects in isolated liver and lung cells. Both compounds were found to cause DNA adducts measured by the 32P-postlabelling technique. The level of DNA-adducts in rat hepatocytes exposed to 30 μg/ml B[l]A and B[j]A for 4 h were 46.5 ± 22.0 and 8.3 ± 5.1 fmol/μg DNA respectively. Using butanol extractions, the major and one of the minor B[l] A adducts co-chromatographed with B[j]A-l, 2-oxide adducts of 2'-deoxyadenosine and 2'-deoxyguanosine. Thus, oxidation at the cyclopenta-ring of B[j]A appears to be an important activation pathway. In hepatocytes, 3-30 μg/ml of B[j]A and B[j]A induced DNA damage and repair measured both as increased alkaline elution of DNA and as increased incorporation of [3H]TdR in the DNA. B[l]A was somewhat more potent than B[j]A in inducing DNA repair. Reactive CP-PAH intermediates formed in the hepatocytes caused mutations in Salmonella typhimurium TA98 upon co-incubation. DNA adducts were also observed in isolated rabbit lung cells exposed to 30 μg/ml B[l]A or B[j]A for 2 h. A total of 14.5 ± 6.9, 2.9 ± 2.1 and 0.2 ± 0.6 fmol B[l] A adducts/μg DNA were observed in Clara cells, type II pneumocytes and alveolar macrophages respectively. The main B[l]A adduct observed in the liver cells was not found in the lung cells. On the other hand, the levels of B[j]A adducts in the lung cells were in the range 4-14% of that found in liver cells, and no major differences between the various lung cells were observed. Neither B[l]A nor B[j]A induced DNA damage measured by alkaline elution in the lung cells, indicating that these adducts are not alkali labile.
- 1 June 1993
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 14 (6) , 1125-1131
Genotoxic effects of cyclopenta-fused polycyclic aromatic hydrocarbons in isolated rat hepatocytes and rabbit lung cells
Benz[j]aceanthrylene (B[j]A) and benz[l)aceanthrylene (B[l]A), two isomeric cyclopenta polycyclic aromatic hydrocarbons (CP-PAH) structurally related to 3-methylcholanthrene, were studied with respect to their genotoxic effects in isolated liver and lung cells. Both compounds were found to cause DNA adducts measured by the 32P-postlabelling technique. The level of DNA-adducts in rat hepatocytes exposed to 30 μg/ml B[l]A and B[j]A for 4 h were 46.5 ± 22.0 and 8.3 ± 5.1 fmol/μg DNA respectively. Using butanol extractions, the major and one of the minor B[l] A adducts co-chromatographed with B[j]A-l, 2-oxide adducts of 2'-deoxyadenosine and 2'-deoxyguanosine. Thus, oxidation at the cyclopenta-ring of B[j]A appears to be an important activation pathway. In hepatocytes, 3-30 μg/ml of B[j]A and B[j]A induced DNA damage and repair measured both as increased alkaline elution of DNA and as increased incorporation of [3H]TdR in the DNA. B[l]A was somewhat more potent than B[j]A in inducing DNA repair. Reactive CP-PAH intermediates formed in the hepatocytes caused mutations in Salmonella typhimurium TA98 upon co-incubation. DNA adducts were also observed in isolated rabbit lung cells exposed to 30 μg/ml B[l]A or B[j]A for 2 h. A total of 14.5 ± 6.9, 2.9 ± 2.1 and 0.2 ± 0.6 fmol B[l] A adducts/μg DNA were observed in Clara cells, type II pneumocytes and alveolar macrophages respectively. The main B[l]A adduct observed in the liver cells was not found in the lung cells. On the other hand, the levels of B[j]A adducts in the lung cells were in the range 4-14% of that found in liver cells, and no major differences between the various lung cells were observed. Neither B[l]A nor B[j]A induced DNA damage measured by alkaline elution in the lung cells, indicating that these adducts are not alkali labile.
- 1 January 1991
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 6 (1) , 25-30
Co-culture systems for assessing the stability and genotoxicity of reactive 1, 2-dibromo-3-chloropropane (DBCP) metabolites
1, 2-Dibromo-3-choloropropane (DBCP) induced DNA damage, measured by alkaline elution, at low concentrations (5–10μM) in suspensions of hepatocytes and testicular cells isolated from rats. At higher concentrations(≥ 100μM) DBCP caused DNA damage and increased the frequency of sister chromatid exchanges in Chinese hamster V79 cells. When DBCP (2. 5–10μM) was tested for its ability to cause unscheduled DNA synthesis (UDS) in monolayers of liver cells isolated from untreated rats, a clear positive response was obtained. No increase in UDS was detectable when liver cells isolated from PCB-pretreated rats were used. In contrast, DBCP (50μM) was metabolized in hepatocytes from PCB-pretreated rats to products mutagenic to Salmonella typhimurium TA100 in co-culture with the hepatocytes, whereas control hepatocyotes were substantially (40-fold) less active. No bacterial mutagenicity could be detected when the TA100 strain was co-incubated with isolated rat testicular cells and DBCP. In concultures of hepatocytes and V79 cells DBCP-induced DNA damage in V79 cells occurred at low concentrations (10μM DBCP) compared to the concentration (100μM) needed to induce DNA damage in the V79 cells incubated without hepatocytes. Testicular cells were not able to enhance DBCP-induced DNA damage in the V79 cells. The data indicate that the putative reactive DBCP episulphonium ion metabolite formed in the lesticular cells presumably responsible for testicular cell DNA damage, is not capable of escaping the cell where it is formed. Other reactive DBCP metabolites generated in the liver cells seem to be able to interact with the DNA of neighbouring cells.
- 1 January 1991
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 6 (1) , 25-30
Co-culture systems for assessing the stability and genotoxicity of reactive 1, 2-dibromo-3-chloropropane (DBCP) metabolites
1, 2-Dibromo-3-choloropropane (DBCP) induced DNA damage, measured by alkaline elution, at low concentrations (5–10μM) in suspensions of hepatocytes and testicular cells isolated from rats. At higher concentrations(≥ 100μM) DBCP caused DNA damage and increased the frequency of sister chromatid exchanges in Chinese hamster V79 cells. When DBCP (2. 5–10μM) was tested for its ability to cause unscheduled DNA synthesis (UDS) in monolayers of liver cells isolated from untreated rats, a clear positive response was obtained. No increase in UDS was detectable when liver cells isolated from PCB-pretreated rats were used. In contrast, DBCP (50μM) was metabolized in hepatocytes from PCB-pretreated rats to products mutagenic to Salmonella typhimurium TA100 in co-culture with the hepatocytes, whereas control hepatocyotes were substantially (40-fold) less active. No bacterial mutagenicity could be detected when the TA100 strain was co-incubated with isolated rat testicular cells and DBCP. In concultures of hepatocytes and V79 cells DBCP-induced DNA damage in V79 cells occurred at low concentrations (10μM DBCP) compared to the concentration (100μM) needed to induce DNA damage in the V79 cells incubated without hepatocytes. Testicular cells were not able to enhance DBCP-induced DNA damage in the V79 cells. The data indicate that the putative reactive DBCP episulphonium ion metabolite formed in the lesticular cells presumably responsible for testicular cell DNA damage, is not capable of escaping the cell where it is formed. Other reactive DBCP metabolites generated in the liver cells seem to be able to interact with the DNA of neighbouring cells.